Solta Medical Launches New Fraxel re:store(R) Dual Laser System
August 26 2009 - 9:00AM
PR Newswire (US)
Breakthrough Skin Resurfacing Technology for Faster Clearance of
Pigment and Advanced Off-Face Treatments HAYWARD, Calif., Aug. 26
/PRNewswire-FirstCall/ -- Solta Medical, Inc. (NASDAQ:SLTM) today
announced the launch of its new Fraxel re:store Dual system,
providing superior results for large body areas during a single
treatment. Prior to the non-ablative Fraxel re:store Dual system,
laser skin resurfacing procedures were largely limited to the face.
The Fraxel re:store Dual takes the industry leading fractional
laser technology to the next level by adding a novel 1927 nm
wavelength, the first ever application of a Thulium laser in the
aesthetics market, optimized for treatment of pigmentation and
other superficial skin conditions. (Photo:
http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-a) (Photo:
http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-b) "The
expanded versatility of the Fraxel re:store Dual system, with the
addition of the new 1927 nm wavelength, increases the areas of the
body that I can treat and provides a superior treatment for
pigmentation and actinic keratoses associated with photodamage,"
said Roy Geronemus, MD, director of the Laser & Skin Surgery
Center of New York. Vic Narurkar, MD, founder of the Bay Area Laser
Institute added, "The Fraxel re:store Dual allows me to offer
patients the safety, comfort and minimal downtime of a non-ablative
treatment, and achieve results superior to superficial fractional
CO2 treatments." The product launch comes on the heels of Solta's
announcement last week of the new Thermage CPT(TM) system for skin
tightening and body contouring. Together, these cutting edge
developments further secure Solta's leadership position in the
aesthetic energy device industry. "Solta Medical is committed to
developing innovative, safe, and effective anti-aging solutions
that enhance and expand the practice of medical aesthetics for our
physician customers," said Stephen J. Fanning, Chairman of the
Board, President and CEO of Solta Medical, Inc. "With the launch of
a major new product from each of our industry-leading Thermage and
Fraxel brands, Solta takes another step forward in fulfilling our
mission to be the leader in developing transformational aesthetic
treatments, building world class brands and providing long-term
value for our stakeholders." Fraxel re:store Dual system features
and benefits include: -- Dual fiber laser technology in one system
providing the most effective non-ablative skin resurfacing
treatment -- Accelerated clearance of unwanted pigmentation via
ground-breaking use of a Thulium laser -- Ease of operation and
improved patient comfort with focal cooling built directly into the
hand piece -- Treatment of larger and multiple body areas in a
single session due to enhanced comfort profile with 1927 nm
wavelength -- Increased procedure speed by 25% with newly improved
scanner design Solta Medical is proud to be celebrating the launch
of this new product along with the Thermage CPT system through the
illumiNATION tour. Beginning in September and continuing through
November, the illumiNATION tour will bring the new Fraxel re:store
Dual system and Thermage CPT system to physicians in over 20 cities
across the U.S. and 11 cities in Europe on board a
state-of-the-art, custom-outfitted Airstream . Come join the
excitement by visiting http://www.illuminationtour.com/ for more
information and to register for a tour stop. ABOUT SOLTA MEDICAL,
INC. Solta Medical is a global leader in the medical aesthetics
market providing innovative, safe, and effective anti-aging
solutions for patients that enhance and expand the practice of
medical aesthetics for physicians. The company offers products to
address aging skin under the industry's two premier brands:
Thermage and Fraxel . Thermage is an innovative, non-invasive
radiofrequency procedure for tightening and contouring skin. As the
leader in fractional laser technology, Fraxel delivers minimally
invasive clinical solutions to resurface aging and sun damaged
skin. Since 2002, approximately one million Thermage and Fraxel
procedures have been performed in nearly 80 countries. Thermage and
Fraxel are the perfect complement for any aesthetic practice. For
more information about Solta Medical, call 1-877-782-2286 or log on
to http://www.solta.com/. The Fraxel re:store 1550 nm laser is FDA
cleared for the treatment of pigmented lesions, acne scars,
melasma, mild to moderate periorbital rhytids, surgical scars and
actinic keratosis. The Fraxel re:store 1927 nm wavelength is
pending FDA 510(k) clearance. 2009 Solta Medical, Inc. All rights
reserved. Thermage, Fraxel, Fraxel re:store and Solta Medical are
trademarks or registered trademarks of Solta Medical, Inc. or its
subsidiaries.
http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-a
http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-b
http://photoarchive.ap.org/ DATASOURCE: Solta Medical, Inc.
CONTACT: Michael Hromadik of Solta Medical, Inc., +1-510-780-4694,
; or Media Relations, Chris Lalli of Cohn & Wolfe,
+1-415-365-8540, , for Solta Medical, Inc. Web Site:
http://www.solta.com/
Copyright